Literature DB >> 24981063

[Noncardiological surgical procedure for patients implanted with a ventricular assist device. Anesthesiological management concepts].

F E Blum1.   

Abstract

BACKGROUND: The implantation of a ventricular assist device (VAD) is more frequently used as destination therapy of end-stage heart failure compared to the use of the device as bridge-to-transplantation, this results in an increasing number of noncardiac surgical procedures for patients implanted with a VAD.
OBJECTIVE: For these procedures, the anesthesia provider faces various device-related complications, such as an increased risk for bleeding complications, thromboembolism, hypotension, infections, mechanical device limitations, and right heart failure. Anesthesia care is challenging in this high-risk patient population and has significant implications on patient outcome.
CONCLUSION: More research is needed to determine specific guidelines for the anesthesiological management of VAD patients undergoing noncardiac surgical procedures. In this manuscript, device-related perioperative complications and concepts of anesthesia care for noncardiac procedures in patients implanted with a VAD are briefly reviewed.

Entities:  

Mesh:

Year:  2014        PMID: 24981063     DOI: 10.1007/s00063-014-0398-4

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  45 in total

1.  Noncardiac surgery in patients with left ventricular assist devices.

Authors:  C Schmid; M Wilhelm; K H Dietl; C Schmidt; D Hammel; H H Scheld
Journal:  Surgery       Date:  2001-04       Impact factor: 3.982

2.  Implantable left ventricular assist devices can successfully bridge adolescent patients to transplant.

Authors:  D N Helman; L J Addonizio; D L Morales; K A Catanese; M A Flannery; J M Quagebeur; N M Edwards; M E Galantowicz; M C Oz
Journal:  J Heart Lung Transplant       Date:  2000-02       Impact factor: 10.247

3.  Anaesthesia for non-cardiac surgery in patient with Becker's muscular dystrophy supported with a left ventricular assist device.

Authors:  S T Webb; V Patil; A Vuylsteke
Journal:  Eur J Anaesthesiol       Date:  2007-07       Impact factor: 4.330

Review 4.  Management of patients with implanted ventricular assist devices for noncardiac surgery: a clinical review.

Authors:  Eugene A Hessel
Journal:  Semin Cardiothorac Vasc Anesth       Date:  2013-10-16

Review 5.  Pharmacogenetics of warfarin: challenges and opportunities.

Authors:  Ming Ta Michael Lee; Teri E Klein
Journal:  J Hum Genet       Date:  2013-05-09       Impact factor: 3.172

6.  Complex HeartMate II infection treated with pump exchange to HeartWare HVAD.

Authors:  Travis Abicht; Robert Gordon; Karen Meehan; Valentina Stosor; Patrick McCarthy; Edwin McGee
Journal:  ASAIO J       Date:  2013 Mar-Apr       Impact factor: 2.872

7.  Lung lobectomy in a patient with an implantable left ventricular assist device.

Authors:  Tomohiro Murakawa; Tomonori Murayama; Jun Nakajima; Minoru Ono
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-09-04

8.  Use of a continuous-flow device in patients awaiting heart transplantation.

Authors:  Leslie W Miller; Francis D Pagani; Stuart D Russell; Ranjit John; Andrew J Boyle; Keith D Aaronson; John V Conte; Yoshifumi Naka; Donna Mancini; Reynolds M Delgado; Thomas E MacGillivray; David J Farrar; O H Frazier
Journal:  N Engl J Med       Date:  2007-08-30       Impact factor: 91.245

9.  Does the need for noncardiac surgery during ventricular assist device therapy impact clinical outcome?

Authors:  Joshua B Brown; William M Hallinan; Howard T Massey; Paul E Bankey; Julius D Cheng; Nicole A Stassen; Ayodele T Sangosanya; Mark L Gestring
Journal:  Surgery       Date:  2009-10       Impact factor: 3.982

10.  Thrombosis and cable damage in the HeartWare pump: clinical decisions and surgical technique.

Authors:  Evgenij V Potapov; Alexander Stepanenko; Friedrich Kaufmann; Ewald Henning; Juliana Vierecke; Elke Lehmkuhl; Roland Hetzer; Thomas Krabatsch
Journal:  ASAIO J       Date:  2013 Jan-Feb       Impact factor: 2.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.